Characterization of the anti-tumor immune response in human cancers and strategies for immunotherapy
Open Access
- 30 June 1994
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 16 (3) , 157-179
- https://doi.org/10.1016/1040-8428(94)90069-8
Abstract
No abstract availableThis publication has 218 references indexed in Scilit:
- Clinical application of IL6 in cancer therapyResearch in Immunology, 1992
- Analysis of T cell receptor β and γ genes from peripheral blood, regional lymph node and tumor-infiltrating lymphocyte clones from melanoma patientsCancer Immunology, Immunotherapy, 1991
- Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumorsCancer Immunology, Immunotherapy, 1991
- Lymphocyte antigen receptors: a common design?Immunology Today, 1991
- Purification of an autoantigenic 75‐kDa human melanosomal glycoproteinInternational Journal of Cancer, 1991
- Sustained outgrowth of autotumor-reactive T lymphocytes from human ovarian carcinomas in the presence of tumor necrosis factor α and interleukin 2Human Immunology, 1990
- Cytostatic and cytotoxic activity of lymphokine-activated killer cell supernatantsCancer Immunology, Immunotherapy, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985